Table 3.
CAFG group | Control group | p | |||
---|---|---|---|---|---|
Number of patients | 76 | 76 | |||
Male:Female | 32:44 | 21:55 | 0.06 | ||
Age, years (mean [SD]) | 16.4 | [3.7] | 15.5 | [3.4] | 0.12 |
Body mass index, kg/m2 (mean [SD]) | 17.9 | [3.6] | 18.2 | [3.3] | 0.55 |
Number of fused vertebras (mean [SD]) | 11.3 | [3.8] | 10.9 | [3.1] | 0.40 |
Cobb angle of major curve, ° (mean [SD]) | 62.3 | [24.3] | 59.7 | [19.3] | 0.47 |
Etiology of spinal deformity (%) | 0.11 | ||||
Congenital or structural | 7 | (9.2) | 4 | (5.3) | |
Neuromuscular | 16 | (21.1) | 9 | (11.8) | |
Syndromic | 11 | (14.4) | 8 | (10.5) | |
Idiopathic | 40 | (52.6) | 55 | (72.4) | |
L5 spondylolisthesis | 2 | (2.6) | |||
Perioperative allogenic blood transfusion (%) | 1 | (1.3) | 3 | (3.9) | 0.62 |
Wound-related reoperations within 90 days (%) | 2 | (2.6) | 4 | (5.2) | 0.68 |
(deep SSI: 1) (superficial SSI: 1) |
(deep SSI: 3) (wound dehiscence: 1) |
CAFG, completely autologous fibrin glue; SSI, surgical site infection